Dr. Anne Vankeerbergen, molecular biologist at OLVZ, is responsible for developing and validating new qPCR tests and monitors their performance in routine diagnostics.
In this short interview you'll learn how OLVZ Aalst automated their lab-developed syndromic panels. For the full story, grab the case study below.
The molecular diagnostics lab at the OLVZ Aalst hospital designed and developed their syndromic assays in-house, and standardized them on a single platform, extraction and PCR protocol, instrumentation, and data analysis pipeline.
With a fully automated workflow in place - from sample to answer submitted into the LIS - OLVZ guarantees same day results for a wide panel of pathogens.